Previous Article | Next Article 
Journal of Clinical Microbiology, August 2005, p. 4175-4177, Vol. 43, No. 8
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.8.4175-4177.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Reduced Rate of Diagnostic Positive Detection of JC Virus DNA in Cerebrospinal Fluid in Cases of Suspected Progressive Multifocal Leukoencephalopathy in the Era of Potent Antiretroviral Therapy
Angela Marzocchetti,*
Simona Di Giambenedetto,
Antonella Cingolani,
Adriana Ammassari,
Roberto Cauda, and
Andrea De Luca
Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy
Received 1 July 2004/
Returned for modification 20 September 2004/
Accepted 22 April 2005
Fifty-nine human immunodeficiency virus (HIV)-infected patients with suspected progressive multifocal leukoencephalopathy and 224 controls were tested for JC virus (JCV) DNA in cerebrospinal fluid by PCR. The diagnostic positive detection rate dropped from 89.5% (95% confidence intervals of 75.5 to 103.5%) in the pre-highly active antiretroviral therapy (HAART) era to 57.5% (95% confidence intervals of 42.1 to 72.9%) in the HAART era; the specificity remained unchanged. Predictors of failure to detect JCV DNA were exposure to HAART at disease onset and higher CD4 counts.
* Corresponding author. Mailing address: Istituto di Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Largo Gemelli, 8, 00168 Rome, Italy. Phone: 39-0630155366. Fax: 39-063054519. E-mail:
angela.marzocchetti{at}tin.it.
Journal of Clinical Microbiology, August 2005, p. 4175-4177, Vol. 43, No. 8
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.8.4175-4177.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Tornatore, C., Clifford, D. B
(2009). Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use. Mult Scler
15: S16-S25
[Abstract]
-
Linda, H., von Heijne, A., Major, E. O., Ryschkewitsch, C., Berg, J., Olsson, T., Martin, C.
(2009). Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy. NEJM
361: 1081-1087
[Abstract]
[Full Text]
-
Yaldizli, O., Putzki, N.
(2009). Review: Natalizumab in the treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders
2: 115-128
[Abstract]
-
Wang, Y., Kirby, J. E., Qian, Q.
(2009). Effective use of JC virus PCR for diagnosis of progressive multifocal leukoencephalopathy. J Med Microbiol
58: 253-255
[Abstract]
[Full Text]
-
Smith, A. B., Smirniotopoulos, J. G., Rushing, E. J.
(2008). From the Archives of the AFIP@;DELIM@;Continuing Medical Education: Central Nervous System Infections Associated with Human Immunodeficiency Virus Infection: Radiologic-Pathologic Correlation1. RadioGraphics
28: 2033-2058
[Abstract]
[Full Text]
-
Clifford, D. B
(2008). Natalizumab and PML: a risky business?. Gut
57: 1347-1349
[Full Text]
-
Hatfield, M. K., Handrich, S. J., Willis, J. A., Beres, R. A., Zaleski, G. X.
(2008). Blood Patch Rates After Lumbar Puncture with Whitacre Versus Quincke 22- and 20-Gauge Spinal Needles. Am. J. Roentgenol.
190: 1686-1689
[Abstract]
[Full Text]